Everolimus Rowex 5mg Tablets

Licence status
Withdrawn: 03/08/2023
Active substances
Everolimus
Dosage Form
Tablet
Licence number
PA0711/290/002
Licence holder
Rowex Ltd

Product documents

Licence information

ATC code
L01EG02 everolimus, L01XE Protein kinase inhibitors, L01XE10 everolimus
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/09/2019